> Ongoing global scrutiny tied to Indian CROs and CMOs is hampering the nation's effort to become a go-to outlet for biopharma R&D, and now the country's diplomats are working to improve the domestic industry's reputation around the world. Story
> Parexel ($PRXL) has updated its eClinical technology, Perceptive MyTrials, to include a mobile-friendly platform that allows sponsors to monitor predictive data analytics for multiple studies at the same time. More
> An independent lab network has bought into the CRO industry, paying an undisclosed sum for Analytical Bio-Chemistry Laboratories. News